Orthocell to raise $18m

04/12/2019 - 12:05

Bookmark

Save articles for future reference.

Bio-therapeutic company Orthocell has received commitments to raise $13 million from a share placement and up to a further $5 million from a share purchase plan, primarily to accelerate the commercialisation of its CelGro flagship product.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options